← back to search

Li Z

Peking University · CN
Area of research
Cancer Research · Molecular Biology
Research interest
Research interests include Cancer-related molecular mechanisms research, MicroRNA in disease regulation, Circular RNAs in diseases, and Liver Disease Diagnosis and Treatment.
h-index
24
citations
2,830
works
594
NIH funding
primary concept
email

Recent publications

Preliminary study results of orelabrutinib in combination with rituximab for treatment-Naïve marginal zone lymphoma: A prospective single-arm clinical trial
Blood 2025cited by 1position: firstdoi
Neoadjuvant chemotherapy versus surgery alone in locally advanced esophageal squamous cell carcinoma: a propensity-matched real-world study
Frontiers in Oncology 2025cited by 0position: middledoi
Small Extracellular Vesicles Laden Oxygen-Releasing Thermosensitive Hydrogel for Enhanced Antibacterial Therapy against Anaerobe-Induced Periodontitis Alveolar Bone Defect
ACS Biomaterials Science & Engineering 2024cited by 21position: middledoi
The novel miR-873-5p-YWHAE-PI3K/AKT axis is involved in non-small cell lung cancer progression and chemoresistance by mediating autophagy
Functional & Integrative Genomics 2024cited by 7position: firstdoi
The Therapeutic Effects of MUC1-C shRNA@Fe3O4 Magnetic Nanoparticles in Alternating Magnetic Fields on Triple-Negative Breast Cancer
International Journal of Nanomedicine 2023cited by 27position: firstdoi
Update Results of a Phase II Trial of Venetoclax in Combination with Azacitidine and Chidamide in Relapsed/Refractory Acute Myeloid Leukemia
Blood 2023cited by 5position: middledoi
Advances in MUC1-Mediated Breast Cancer Immunotherapy
Biomolecules 2022cited by 19position: firstdoi
The Therapeutic Effects of DDP/CD44-shRNA Nanoliposomes in AMF on Ovarian Cancer
Frontiers in Oncology 2022cited by 11position: middledoi
Pathological complete response to radical surgery after receiving durvalumab plus neoadjuvant chemotherapy for 1 limited-stage small cell lung cancer patient: a case report
Translational Cancer Research 2022cited by 5position: firstdoi
Preclinical Studies and Phase II Trial of Venetoclax in Combination with Chidamide and Azacitidine in Relapsed/Refractory Acute Myeloid Leukemia
Blood 2022cited by 5position: middledoi
Advances in PSMA-targeted therapy for prostate cancer
Prostate Cancer and Prostatic Diseases 2021cited by 142position: middledoi
PEI-PEG-Coated Mesoporous Silica Nanoparticles Enhance the Antitumor Activity of Tanshinone IIA and Serve as a Gene Transfer Vector
Evidence-based Complementary and Alternative Medicine 2021cited by 23position: middledoi
Long Noncoding RNAs Regulate the Radioresistance of Breast Cancer
Analytical Cellular Pathology 2021cited by 13position: firstdoi
Research Progress on Long Non-Coding RNA and Radiotherapy
Medical Science Monitor 2019cited by 25position: lastdoi
Nucleotide exchange factor SIL1 promotes the progress of breast cancer cells via regulating the cell cycle and apoptosis
Science Progress 2019cited by 7position: firstdoi
Puerarin promotes DUSP1 expression by regulating miR‑133a‑3p in breast cancer
Molecular Medicine Reports 2018cited by 21position: firstdoi
[The pilot study on the expression of PHF8, H3K9me2, BDNF and LTP in the hippocampus of rats exposed to aluminum].
PubMed 2016cited by 4position: firstdoi
Selective class I histone deacetylase inhibitors suppress persistent spontaneous nociception and thermal hypersensitivity in a rat model of bee venom-induced inflammatory pain.
PubMed 2015cited by 5position: middle
Coexistence of low ankle-brachial index and intra-cranial atherosclerosis?
PubMed 2014cited by 6position: first
Extraordinary expansion of a Sorangium cellulosum genome from an alkaline milieu
Scientific Reports 2013cited by 135position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Mei Lin · Sun Yat-sen University Cancer Center6 papers (2021–2023)Ting Guo · Nanjing University of Chinese Medicine5 papers (2021–2023)Fujin Wang · Nanjing University of Chinese Medicine3 papers (2021–2022)Yinxing Zhu · Nanjing University of Chinese Medicine3 papers (2021–2022)Dazhuang Yang · Nantong University3 papers (2021–2022)Zhijuan Lin · Houston Methodist3 papers (2022–2025)Jinhua Xu · Jilin Province Tumor Hospital2 papers (2018–2019)Jie Zha · University of Florida2 papers (2022–2023)Yirong Jiang · Southern Medical University2 papers (2022–2023)Biyun Chen · Fujian Medical University2 papers (2022–2023)Liwei Yang · Hebei Medical University2 papers (2022–2024)Xianqi Feng · Beijing Institute of Technology2 papers (2022–2023)Tiejun Gong · Harbin Medical University2 papers (2022–2023)Zhenling Li · Jilin University2 papers (2022–2023)Lin Yang · Hebei Medical University2 papers (2022–2023)Ying Xie · Shanxi Medical University2 papers (2022–2023) · 2 papers (2022–2023) · 2 papers (2022–2023)Weiwei Xu · Fudan University2 papers (2018–2019)Ying Wang · Shanghai Jiao Tong University2 papers (2022–2023)